Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy

Subhadra Priyadarshini Narayanan, Esraa Shosha, Chithra D. Palani

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Diabetic Retinopathy (DR), is a significant public health issue and the leading cause of blindness in working-aged adults worldwide. The vision loss associated with DR affects patients’ quality of life and has negative social and psychological effects. In the past, diabetic retinopathy was considered as a vascular disease; however, it is now recognized to be a neuro-vascular disease of the retina. Current therapies for DR, such as laser photocoagulation and anti-VEGF therapy, treat advanced stages of the disease, particularly the vasculopathy and have adverse side effects. Unavailability of effective treatments to prevent the incidence or progression of DR is a major clinical problem. There is a great need for therapeutic interventions capable of preventing retinal damage in DR patients. A growing body of evidence shows that neurodegeneration is an early event in DR pathogenesis. Therefore, studies of the underlying mechanisms that lead to neurodegeneration are essential for identifying new therapeutic targets in the early stages of DR. Deregulation of the polyamine metabolism is implicated in various neurodegenerative diseases, cancer, renal failure, and diabetes. Spermine Oxidase (SMOX) is a highly inducible enzyme, and its dysregulation can alter polyamine homeostasis. The oxidative products of polyamine metabolism are capable of inducing cell damage and death. The current review provides insight into the SMOX-regulated molecular mechanisms of cellular damage and dysfunction, and its potential as a therapeutic target for diabetic retinopathy. Structural and functional changes in the diabetic retina and the mechanisms leading to neuronal damage (excitotoxicity, loss of neurotrophic factors, oxidative stress, etc.) are also summarized in this review. Furthermore, existing therapies and new approaches to neuroprotection are discussed.

Original languageEnglish (US)
Article number104299
JournalPharmacological Research
StatePublished - Sep 2019


  • Diabetic retinopathy
  • Neurodegeneration
  • Neuroprotection
  • Oxidative stress
  • Polyamine metabolism
  • Spermine oxidase

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy'. Together they form a unique fingerprint.

Cite this